First reported 22 hours ago -
Updated 22 hours ago -
WASHINGTON, D.C. - The question of whether a patent licensee bears the burden of proving that its products do not infringe in a declaratory judgment action filed pursuant to MedImmune Inc. v. Genentech Inc
. (549 U.S. 118, 137 $(2007$)) will be decided ...
[Published Mealey - 22 hours ago]